AdvisorShares Psychedelic... (PSIL)
NYSEArca: PSIL
· 실시간 가격 · USD
25.43
+0.52 (2.09%)
종가 기준: Aug 12, 2026, 3:57 PM
25.43
+0.00%
애프터마켓: 4:15 PM
AdvisorShares Psychedelics ETF (PSIL) ETF Price, Holdings & Analysis
2.09% (1D)
| 매수호가 | 25.27 |
| 시가총액 | n/a |
| 운용자산 | 48.53M |
| 순자산가치 | 24.57 |
| 베타 | 0.56 |
| EPS (최근 12개월) | n/a |
| P/E (최근 12개월) | n/a |
| 발행 주식수 | n/a |
| 설정일 | Sep 15, 2021 |
| 매도호가 | 25.43 |
| 거래량 | 23,595 |
| 평균 거래량 (20일) | 38,703 |
| 시가 | 25.36 |
| 전일 종가 | 24.91 |
| 당일 변동폭 | 25.03 - 25.50 |
| 52주 변동폭 | 15.36 - 25.73 |
| 편입 종목 | n/a |
| 총보수 | 1.00% |
PSIL 정보
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.
상위 10종목 자산의 70.03%
| 이름 | 종목코드 | 비중 |
|---|---|---|
| Ataibeckley Inc | ATAI | 14.15% |
| Definium Therapeutic... | DFTX | 12.05% |
| Compass Pathways PLC... | CMPS | 9.83% |
| Helus Pharma Inc Ord... | HELP.NE | 5.47% |
| Relmada Therapeutics... | RLMD | 5.32% |
| Gh Research PLC | GHRS | 4.82% |
| Nrx Pharmaceuticals ... | NRXP | 4.74% |
| Neurocrine Bioscienc... | NBIX | 4.66% |
| Alto Neuroscience In... | ANRO | 4.55% |
| Bright Minds Bioscie... | DRUG.CN | 4.44% |
배당 배당수익률 7.39%
| 배당락일 | 금액 | 지급일 |
|---|---|---|
| Dec 22, 2025 | $1.6840 | n/a |
| Sep 22, 2025 | $0.0200 | n/a |
| Jun 23, 2025 | $0.0120 | n/a |
| Mar 21, 2025 | $0.1630 | n/a |
| Dec 23, 2024 | $0.0550 | n/a |
